ACM Research Inc (ACMR) concluded trading on Wednesday at a closing price of $27.69, with 5.94 million shares of worth about $164.57 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 42.07% during that period and on Wednesday the price saw a gain of about 20.71%. Currently the company’s common shares owned by public are about 57.52M shares, out of which, 48.71M shares are available for trading.
Stock saw a price change of 4.73% in past 5 days and over the past one month there was a price change of 60.80%. Year-to-date (YTD), ACMR shares are showing a performance of 83.38% which increased to 35.14% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.87 but also hit the highest price of $34.40 during that period. The average intraday trading volume for ACM Research Inc shares is 1.56 million. The stock is currently trading 20.50% above its 20-day simple moving average (SMA20), while that difference is up 46.19% for SMA50 and it goes to 40.63% higher than SMA200.
ACM Research Inc (NASDAQ: ACMR) currently have 57.52M outstanding shares and institutions hold larger chunk of about 60.09% of that.
The stock has a current market capitalization of $1.73B and its 3Y-monthly beta is at 1.63. PE ratio of stock for trailing 12 months is 20.87, while it has posted earnings per share of $1.33 in the same period. It has Quick Ratio of 1.34 while making debt-to-equity ratio of 0.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACMR, volatility over the week remained 7.59% while standing at 6.00% over the month.
Stock’s fiscal year EPS is expected to drop by -13.99% while it is estimated to increase by 11.38% in next year.
Coverage by Craig Hallum stated ACM Research Inc (ACMR) stock as a Hold in their note to investors on December 05, 2024, suggesting a price target of $18 for the stock. On December 04, 2024, Needham Downgrade their recommendations, while on February 29, 2024, Goldman Upgrade their ratings for the stock with a price target of $39. Stock get a Buy rating from Jefferies on July 03, 2023.
